Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis
- PMID: 7936633
Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis
Abstract
Multistep lymphomagenesis involves the deregulation of oncogenes and inactivation of tumor suppressor genes resulting in altered rates of proliferation as well as apoptotic cell death in tumor cells. The contribution of bcl-2 and p53 to the regulation of cell death during lymphomagenesis is assessed using bcl-2-1g, p53 'knock-out' (p53 KO), and p53 KO/bcl-2 hybrid mice. PCR-SSCP and DNA sequence analysis demonstrated that p53 somatic mutations are uncommon in lymphomas arising in bcl-2-Ig transgenic mice. Reduction in tumor latency was not observed in p53 KO/bcl-2 hybrid mice compared to p53 KO mice. Furthermore, overexpressed bcl-2 suppressed wild-type p53 associated apoptosis following gamma-radiation. These findings indicate that bcl-2 and p53 serve a suppressor and effector function, respectively, of a common cell death pathway. These findings also suggest that p53 somatic mutations provide no selective advantage during in vivo multistep lymphomagenesis in the context of bcl-2 gene deregulation.
Similar articles
-
The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.Exp Cell Res. 1995 Apr;217(2):240-7. doi: 10.1006/excr.1995.1083. Exp Cell Res. 1995. PMID: 7698223
-
Bax accelerates tumorigenesis in p53-deficient mice.Cancer Res. 2001 Jan 15;61(2):659-65. Cancer Res. 2001. PMID: 11212265
-
Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.Oncogene. 2001 Jan 18;20(3):320-8. doi: 10.1038/sj.onc.1204080. Oncogene. 2001. PMID: 11313961
-
The bcl-2 oncogene and apoptosis.Semin Immunol. 1992 Dec;4(6):413-20. Semin Immunol. 1992. PMID: 1286168 Review.
-
Stress-induced p53 runs a transcription-independent death program.Biochem Biophys Res Commun. 2005 Jun 10;331(3):843-50. doi: 10.1016/j.bbrc.2005.03.187. Biochem Biophys Res Commun. 2005. PMID: 15865940 Review.
Cited by
-
In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.Transgenic Res. 2001 Oct;10(5):471-8. doi: 10.1023/a:1012064911751. Transgenic Res. 2001. PMID: 11708657
-
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.Am J Pathol. 2000 Feb;156(2):409-17. doi: 10.1016/S0002-9440(10)64744-X. Am J Pathol. 2000. PMID: 10666369 Free PMC article.
-
Apoptosis and Expression of the Proto-Oncogenes bcl-2 and p53 and the Proliferation Factor Ki-67 in Human Medullary Thyroid Carcinoma.Endocr Pathol. 1996 Spring;7(1):37-45. doi: 10.1007/BF02739913. Endocr Pathol. 1996. PMID: 12114678
-
Programmed cell death and radioresistance.Cancer Metastasis Rev. 1996 Mar;15(1):119-31. doi: 10.1007/BF00049491. Cancer Metastasis Rev. 1996. PMID: 8842483 Review.
-
Localization of the cell proliferation and apoptosis-associated CAS protein in lymphoid neoplasms.Am J Pathol. 1997 Jan;150(1):25-30. Am J Pathol. 1997. PMID: 9006318 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous